Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

Capecitabine, an oral fluoropyrimidine carbamate, was designed to generate 5-fluorouracil preferentially at the tumour site. This randomised, phase II trial evaluated the efficacy and safety of capecitabine or paclitaxel in patients with anthracycline-pretreated metastatic breast cancer. Outpatients...

Descripción completa

Detalles Bibliográficos
Autores principales: Talbot, D C, Moiseyenko, V, Van Belle, S, O'Reilly, S M, Alba Conejo, E, Ackland, S, Eisenberg, P, Melnychuk, D, Pienkowski, T, Burger, H-U, Laws, S, Osterwalder, B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375384/
https://www.ncbi.nlm.nih.gov/pubmed/11986765
http://dx.doi.org/10.1038/sj.bjc.6600261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375384/
https://www.ncbi.nlm.nih.gov/pubmed/11986765
http://dx.doi.org/10.1038/sj.bjc.6600261

Ejemplares similares